nevirapine

Generic: nevirapine

Labeler: camber pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name nevirapine
Generic Name nevirapine
Labeler camber pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

nevirapine 200 mg/1

Manufacturer
Camber Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 31722-505
Product ID 31722-505_e5515515-0ee0-e288-e053-2995a90a3d7c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA078584
Listing Expiration 2026-12-31
Marketing Start 2012-05-23

Pharmacologic Class

Established (EPC)
human immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor [epc]
Mechanism of Action
non-nucleoside reverse transcriptase inhibitors [moa] cytochrome p450 3a inducers [moa] cytochrome p450 2b6 inducers [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 31722505
Hyphenated Format 31722-505

Supplemental Identifiers

RxCUI
199422
UNII
99DK7FVK1H
NUI
N0000175463 N0000175460 N0000009948 N0000190118 N0000187064

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name nevirapine (source: ndc)
Generic Name nevirapine (source: ndc)
Application Number ANDA078584 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (31722-505-01)
  • 500 TABLET in 1 BOTTLE (31722-505-05)
  • 1000 TABLET in 1 BOTTLE (31722-505-10)
  • 60 TABLET in 1 BOTTLE (31722-505-60)
source: ndc

Packages (4)

31722-505-01 100 TABLET in 1 BOTTLE (31722-505-01) 31722-505-05 500 TABLET in 1 BOTTLE (31722-505-05) 31722-505-10 1000 TABLET in 1 BOTTLE (31722-505-10) 31722-505-60 60 TABLET in 1 BOTTLE (31722-505-60)

Ingredients (1)

nevirapine (200 mg/1)

Linked Drug Pages (1)

Nevirapine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "e5515515-0ee0-e288-e053-2995a90a3d7c", "openfda": {"nui": ["N0000175463", "N0000175460", "N0000009948", "N0000190118", "N0000187064"], "unii": ["99DK7FVK1H"], "rxcui": ["199422"], "spl_set_id": ["61409678-d2f6-42cd-b03d-b26b11b39641"], "pharm_class_epc": ["Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (31722-505-01)", "package_ndc": "31722-505-01", "marketing_start_date": "20120523"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (31722-505-05)", "package_ndc": "31722-505-05", "marketing_start_date": "20120523"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (31722-505-10)", "package_ndc": "31722-505-10", "marketing_start_date": "20120523"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (31722-505-60)", "package_ndc": "31722-505-60", "marketing_start_date": "20120523"}], "brand_name": "Nevirapine", "product_id": "31722-505_e5515515-0ee0-e288-e053-2995a90a3d7c", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Non-Nucleoside Analog [EXT]", "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "31722-505", "generic_name": "Nevirapine", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nevirapine", "active_ingredients": [{"name": "NEVIRAPINE", "strength": "200 mg/1"}], "application_number": "ANDA078584", "marketing_category": "ANDA", "marketing_start_date": "20120523", "listing_expiration_date": "20261231"}